Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 31
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Neurol India ; 69(6): 1518-1523, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34979636

RESUMO

BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is a neuro-developmental disease commonly seen in children and it is diagnosed via extensive interview procedures, behavioral studies, third-party observations, and comprehensive personal history. ADHD causes regional atrophy in brain regions and alters the pattern of functional brain connectivity networks. Automated/computerized methods based on magnetic resonance imaging (MRI) can replace subjective methods for the identification of ADHD. OBJECTIVES: The aim of this study was to analyze various machine-learning algorithms for ADHD by feeding in vital input features extracted from functional brain connectivity and different existing methods and to review factors crucial for the diagnosis of ADHD. METHODS: This paper is a concise review of machine learning methods for the diagnosis of ADHD from MRI. Techniques for feature extraction, dimensionality reduction/feature selection, and classification, employed in the computerized techniques for the diagnosis of ADHD from MRI and the accuracy of classification offered by the individual methods, are focussed on the review. CONCLUSIONS: Machine learning algorithms with features of functional brain connectivity networks as input, with hierarchical sparse feature elimination, exhibits the highest accuracy. Augmentation of the behavioral features does not contribute much to increased accuracy. The level of accuracy offered by the frameworks meant for the computer-aided diagnosis of ADHD, available in the literature, does not justify their feasibility in clinical practice. Computerized methods that exploit highly specific biomarkers of ADHD like brain iron concentration in Globus Pallidus, Putamen, Caudate nucleus, and thalamus as features are not available.


Assuntos
Transtorno do Deficit de Atenção com Hiperatividade , Transtorno do Deficit de Atenção com Hiperatividade/diagnóstico por imagem , Encéfalo/diagnóstico por imagem , Mapeamento Encefálico , Criança , Humanos , Aprendizado de Máquina , Imageamento por Ressonância Magnética , Espectroscopia de Ressonância Magnética
2.
Mymensingh Med J ; 27(2): 375-381, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29769505

RESUMO

Spinal anaesthesia with local anaesthetics has limited duration. Different additives have been used to prolong spinal anaesthesia. The aim of this study was to determine the efficacy of adding dexamethasone to bupivacaine in spinal anaesthesia specially whether it would prolong the duration of sensory block/ surgical analgesia and post-operative analgesia/pain free period or not. This randomized, prospective, double-blind, clinical study was conducted in the Department of Anaesthesia, Analgesia and Critical Care of Combined Military Hospital, Chittagong from October 2016 to August 2017. Seventy two (72) adult patients scheduled for lower abdominal urological and lower limb orthopedic surgery under spinal anaesthesia were included. They were divided in two groups; each group comprised 36 patients to receive 20mg 0.5% hyperbaric bupivacaine (Bupivacaine group) or 15mg 0.5% hyperbaric bupivacaine plus 5mg dexamethasone (Bupivacaine-Dexamethasone/case group) intrathecally. The patients were evaluated for quality, quantity and duration of sensory block/surgical analgesia, post-operative analgesia/pain free period, blood pressure, heart rate, nausea, and vomiting or other complications. There were no significant differences in demographic data, sensory level and onset time of the sensory block between two groups. Duration of sensory block/Surgical analgesia in the bupivacaine group was 92.32±8.34 minutes and in the bupivacaine- dexamethasone/case group was 122.11±10.59 minutes which was statistically highly significant (p<0.001). The duration of post-operative analgesia/pain free period was 208.78±41.57 minutes in the bupivacaine group; whereas it was 412.82±71.51 minutes in the bupivacaine-dexamethasone/case group which was also statistically highly significant (p<0.001). The frequency of complications was not different between two groups. This study has shown that the addition of dexamethasone to bupivacaine in spinal anaesthesia significantly improved the duration of sensory block/surgical analgesia as well as post-operative analgesia/pain free period without any complications.


Assuntos
Raquianestesia , Anestésicos Locais , Bupivacaína , Dexametasona , Perna (Membro) , Ortopedia , Procedimentos Cirúrgicos Urológicos , Adulto , Raquianestesia/métodos , Anestésicos Locais/administração & dosagem , Bangladesh , Bupivacaína/administração & dosagem , Dexametasona/administração & dosagem , Método Duplo-Cego , Humanos , Perna (Membro)/cirurgia , Estudos Prospectivos
3.
J Assoc Physicians India ; 63(3): 61, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26540847
4.
Indian J Surg ; 77(Suppl 1): 90-1, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25972657

RESUMO

We report a case of parasitic twin or incomplete or heteropagus twining of extra portions of a pelvis, lower and upper limbs, duplication of genitalia and herniation of intestinal tract with spleen-variant of conjoined twinning (CT) consistent with fusion of two embryos followed by resorption of the caudal half of one of them, resulting in a normal male baby with the upper half of a male parasitic twin fused to his chest.

5.
Epilepsia ; 56(2): 168, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25404065
6.
Indian Heart J ; 66(5): 535-8, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25443608

RESUMO

Idiopathic Pulmonary Hypertension (IPAH) is characterized by elevated pulmonary arterial pressure in the absence of an identifiable underlying cause. The condition is usually relentlessly progressive with a short survival in the absence of treatment.(1) We describe a patient of IPAH in whom the pulmonary artery pressures significantly abated with complete disappearance of symptoms, following spontaneous development of a pulmonary arterio-venous malformation (PAVM).


Assuntos
Fístula Arteriovenosa/complicações , Hipertensão Pulmonar/complicações , Artéria Pulmonar/anormalidades , Veias Pulmonares/anormalidades , Adulto , Fístula Arteriovenosa/diagnóstico , Diagnóstico Diferencial , Diagnóstico por Imagem , Feminino , Humanos , Hipertensão Pulmonar/diagnóstico
8.
J Matern Fetal Neonatal Med ; 26(17): 1705-9, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23574458

RESUMO

OBJECTIVE: Cesarean section is associated with more blood loss than vaginal delivery. This could increase the risk of morbidity and mortality especially among anemic women. The objective of the trial is to assess the possible effect of tranexamic acid on blood loss during and after elective cesarean section. METHODS: We conducted a randomized controlled trial at Women's Health Hospital, Assiut University, Assiut, Egypt. All pregnant women with singleton fetus planned to have elective cesarean section at ≥37 wks gestation were randomized to receive 1 g tranexamic acid slowly intravenously over 10 min before elective cesarean section group or not. Blood loss was measured during and for two hours after operation. Any side effects, complications, medications, changes in vital signs and duration of hospital stay were recorded. This study is registered, number ACTRN12612000313831. RESULTS: Seven hundred and forty women were randomized (373 in study group and 367 in control group). Mean total blood loss was 241.6 (SE 6.77) ml in the tranexamic acid group versus 510 (SE 7.72) ml in the control group. The mean drop in hematocrit and hemoglobin levels were statistically significantly lower in the tranexamic acid group than in the control group. There were no statistically or clinically significant differences in other outcomes. CONCLUSIONS: Pre-operative use of tranexamic acid is associated with reduced blood loss during and after elective cesarean section. This could be of benefit for anemic women or those who refuse blood transfusion.


Assuntos
Antifibrinolíticos/uso terapêutico , Perda Sanguínea Cirúrgica/prevenção & controle , Cesárea/efeitos adversos , Hemorragia Pós-Operatória/prevenção & controle , Ácido Tranexâmico/uso terapêutico , Adulto , Perda Sanguínea Cirúrgica/estatística & dados numéricos , Procedimentos Cirúrgicos Eletivos/efeitos adversos , Feminino , Humanos , Período Intraoperatório , Hemorragia Pós-Operatória/epidemiologia , Hemorragia Pós-Parto/epidemiologia , Hemorragia Pós-Parto/prevenção & controle , Gravidez , Resultado do Tratamento , Adulto Jovem
9.
Int J Gen Med ; 3: 127-36, 2010 May 26.
Artigo em Inglês | MEDLINE | ID: mdl-20531975

RESUMO

An aqueous root extract from Nardostachys jatamansi was investigated for its antioxidant and anticataleptic effects in the haloperidol-induced catalepsy rat model of the disease by measuring various behavioral and biochemical parameters. Catalepsy was induced by administration of haloperidol (1 mg/kg, ip) in male albino rats. A significant (P < 0.01) reduction in the cataleptic scores were observed in all the drug-treated groups as compared to the haloperidol-treated group; with maximum reduction observed in the Nardostachys jatamansi (250 and 500 mg/kg body weight) administered group. To estimate biochemical parameters: the generation of thiobarbituric acid reactive substances (TBARS); reduced glutathione (GSH) content and glutathione-dependent enzymes; catalase; and superoxide dismutase (SOD), in the brain were assessed. Haloperidol administration increased generation of TBARS and significantly reduced GSH, which were restored to near normal level with the Nardostachys jatamansi treatment. Catalase and SOD levels were also increased to normal levels, having been reduced significantly by haloperidol administration. Our findings of behavioral studies and biochemical estimations show that Nardostachys jatamansi reversed the haloperidol-induced catalepsy in rats. We conclude that the antioxidant potential has contributed to the reduction in the oxidative stress and catalepsy induced by haloperidol administration.

10.
Minerva Ginecol ; 61(4): 285-98, 2009 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-19745795

RESUMO

Endometriosis is an enigmatic disorder with obscure pathogenesis. The objective of this review was to critically appraise the recent advances in the etiopathogenesis, diagnosis and clinical management of endometriosis. Several studies support the familial role in the initiation of the disease with key roles of endometriosis-associated polymorphisms in the genes that control fibrinolysis, angiogenesis, steroidogesis, aromatization of androgens, proliferation and cytokine production. Many active substances (cytokines, growth factors, hormones and oxidative stress parameters) have been identified in endometriosis patients at different stages of the disease. In addition to the traditional diagnostic role of ultrasonography and CA 125, evidence is accumulating regarding a potential role sonorectovaginography. Currently the routine use of antiflammatory drugs and birth control pills is not supported by evidence. New protocols of medications incorporation new gonadotrophin releasing hormone agonists with add back therapy, androgenic agents and aromatase inhibitors have been proposed. Prospective randomiazed controlled trials proved that surgical treatment of endometriosis is better than placebo for endometriosis related pain and infertility for patients with stage I and II disease.


Assuntos
Endometriose , Biomarcadores , Antígeno Ca-125 , Endometriose/complicações , Endometriose/diagnóstico , Endometriose/diagnóstico por imagem , Endometriose/genética , Endometriose/imunologia , Endometriose/terapia , Feminino , Gastroenteropatias/diagnóstico , Gastroenteropatias/terapia , Humanos , Polimorfismo Genético , Estudos Prospectivos , Ensaios Clínicos Controlados Aleatórios como Assunto , Técnicas Reprodutivas , Ultrassonografia Doppler em Cores , Doenças Urológicas/diagnóstico , Doenças Urológicas/terapia
18.
J Assoc Physicians India ; 49: 1036-8, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11848316

RESUMO

Antiphospholipid antibody syndrome (APS) is now recognized as an important risk factor for young stroke. Recurrent stroke seems to be common in patients with APS and a first stroke, recurrent stroke and vascular dementia are feared consequences of APS. We are reporting a case of primary APS with recurrent stroke presenting as pseudobulbar palsy in an young man.


Assuntos
Síndrome Antifosfolipídica/complicações , Síndrome Antifosfolipídica/diagnóstico , Paralisia Pseudobulbar/etiologia , Adulto , Encéfalo/diagnóstico por imagem , Demência Vascular/etiologia , Humanos , Masculino , Paralisia Pseudobulbar/diagnóstico por imagem , Recidiva , Acidente Vascular Cerebral/etiologia , Tomografia Computadorizada por Raios X
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA